Use of ranolazine for the treatment of cardiovascular diseases

Details Use of ranolazine for the treatment of cardiovascular diseases Use of ranolazine for the treatment of cardiovascular diseases

A - Human Necessities

61

K

A61K 9/00 (2006.01) A61K 31/495 (2006.01) A61K 45/06 (2006.01) A61P 9/00 (2006.01) A61P 9/04 (2006.01) A61P 9/06 (2006.01) A61P 9/10 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2678272

Disclosed is the treatment of patients suffering from cardiovascular diseases with an intravenous (IV) infusion of ranolazine. In one embodiment, the IV infusion of ranolazine is followed by an orally administered sustained release ranolazine dosage formulation to maintain human ranolazine plasma levels at therapeutic levels in patients.

L'invention concerne le traitement de patients souffrant de maladies cardiovasculaires à l'aide d'une perfusion intraveineuse (IV) de ranolazine. Selon un mode de réalisation, la perfusion IV de ranolazine est suivie par l'administration par voie orale d'une formulation posologique de ranolazine à libération prolongée afin de maintenir les niveaux de ranolazine dans le plasma humain à des niveaux thérapeutiques chez des patients.

Affiliated with

Also associated with

Rating

Use of ranolazine for the treatment of cardiovascular diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ranolazine for the treatment of cardiovascular diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ranolazine for the treatment of cardiovascular diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1775074